Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Dosage Regimen: Individualization01:24

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
Purpose of Health Records I01:11

Purpose of Health Records I

The vital purpose of health records is to provide a complete and accurate account of a patient's medical history, including communication, diagnostic and therapeutic orders, care planning, research, and quality review.
Here's a breakdown of how health records serve these purposes:
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Dosage Regimen Designs: Nomograms and Tabulations01:23

Dosage Regimen Designs: Nomograms and Tabulations

Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
Dosage Regimens: Partial Pharmacokinetic Parameters01:01

Dosage Regimens: Partial Pharmacokinetic Parameters

It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of Psychotropic Use and Psychotropic Polypharmacy in a Finnish National Cohort of Persons With Intellectual Disabilities.

Journal of intellectual disability research : JIDR·2026
Same author

Development and validation of the Patient Involvement in Medication Communication at Hospital discharge Questionnaire (PIMCH-Q).

Journal of patient-reported outcomes·2026
Same author

Promoting Sustainable Prescribing-A Case Study Presenting Experiences From Two Swedish Drug and Therapeutics Committees.

Pharmacology research & perspectives·2026
Same author

Authors response to the comments by Muhammad Salman, Muhammad Hammad Chola and Muhammad Hasan on our paper "prescribing patterns of glucagon like peptide-1 receptor agonists in the Swedish capital region: a register-based cross-sectional study".

European journal of clinical pharmacology·2026
Same author

Use of Attention Deficit Hyperactivity Disorder Medication Among Danish Children and Adolescents From 2010 to 2023.

Acta psychiatrica Scandinavica·2026
Same author

A Cross-Sectional Survey of Evidence Needs for Medicinal Products in Europe With a Focus on Real-World Evidence.

Pharmacoepidemiology and drug safety·2026

Related Experiment Videos

Prescribing quality indicators applicable to register data: A scoping review.

Katri Aaltonen1, Fatimah Fathy2, Marja-Lisa Laukkonen3

  • 1INVEST Research Flagship Centre, Faculty of Social Sciences, University of Turku, FI-20014, Finland; The Social Insurance Institution of Finland (Kela), KELA, P.O. Box 10, FI-00056, Finland.

Research in Social & Administrative Pharmacy : RSAP
|June 15, 2026
PubMed
Summary

This study identified numerous prescribing quality indicators (PQIs) from existing evidence, suitable for assessing outpatient prescribing quality using Nordic registers. These indicators provide a foundation for developing robust healthcare quality frameworks.

Related Experiment Videos

Area of Science:

  • Healthcare Quality Assessment
  • Pharmacotherapy Research
  • Public Health Policy

Background:

  • Cross-linkable healthcare register data facilitate the assessment and improvement of prescribing quality.
  • Developing robust quality indicators requires a comprehensive summary of existing evidence.

Purpose of the Study:

  • To identify prescribing quality indicators (PQIs) for population-level assessment of outpatient prescribing.
  • To ensure PQIs are applicable across diverse regions and usable with Nordic healthcare registers.

Main Methods:

  • Conducted a systematic literature search of databases for articles published between 2000-2023.
  • Included studies with explicit PQIs for outpatient prescribing or pharmacotherapy quality, calculable from structured data.
  • Employed exploratory and snowballing strategies to supplement systematic searches.

Main Results:

  • Identified 915 PQIs from 173 articles, with 90% focusing on pharmacotherapy.
  • PQIs covered process dimensions (100%) and effectiveness/safety aspects (96%).
  • Data requirements varied, with 50% needing individual-level dispensing and diagnosis data, and 16% calculable from aggregate data.

Conclusions:

  • Numerous register-applicable PQIs were identified, suitable for various healthcare quality assessment purposes.
  • The findings provide a strong foundation for developing and validating quality frameworks.
  • Further research can build upon these identified PQIs for enhanced prescribing quality assessment.